Imugene Limited (ASX:IMU)
Australia
· Delayed Price · Currency is AUD 0.120
+0.005 (4.35%)
Apr 29, 2026, 4:10 PM AEST
Imugene Market Cap
Imugene has a market cap or net worth of 41.06 million as of April 28, 2026. Its market cap has decreased by -77.08% in one year.
Market Cap
41.06M
Enterprise Value
31.90M
Revenue
3.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 41.06M, an increase of 456.44%. That is a compound annual growth rate of 7.53%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 43.77M |
| Avecho Biotechnology | 40.41M |
| NeuroScientific Biopharmaceuticals | 38.25M |
| Entropy Neurodynamics | 53.85M |
| EZZ Life Science Holdings | 36.24M |
| Prescient Therapeutics | 56.78M |
| Neurizon Therapeutics | 62.34M |
| LTR Pharma | 70.89M |